What Beacon Angels does

Beacon Angels is a Boston-based angel investment group founded in 2006 that provides early-stage equity capital to fast-growing New England startups, with individual investment tickets ranging from $50,000 to $400,000. The group operates as a member-based organization restricted to accredited investors, who share deal flow, conduct due diligence, and collectively decide on investments through a structured monthly meeting process (presentations on the second Tuesday, member-only screening calls on the third Tuesday, held in-person and virtually at 400 Tradecenter Drive, Woburn, MA, on the Gust platform).

The portfolio spans multiple sectors including biotechnology (Avaxia Biologics, GelMEDIX), medical devices (Lenoss Medical), enterprise software (Copiun), mobility (Zipcar), and diagnostics (Boston Heart Diagnostics). Beacon's economic model is investment returns rather than fees: realized exits across the portfolio range from 0.5X to 8X multiples, with notable outcomes including the Zipcar IPO (NASDAQ: ZIP, 2011), Good Technology's unicorn acquisition by BlackBerry (2015), Copiun's acquisition by Good Technology (2012), and Smartcells' acquisition by Merck. The group is a member of the Angel Capital Association and frequently co-invests with peer Boston-area angel networks including TiE Boston Angels, Boston Harbor Angels, Launchpad Venture Group, Cherrystone Angels, and Mass Medical Angels, as well as institutional funds such as Safar Partners and HTL Biotechnology.

Beacon's go-to-market centers on monthly meetings, a WordPress-hosted website with 152,071+ lifetime hits and 47 newsletter subscribers, and direct outreach through the [email protected] contact channel. The group has no disclosed institutional backing, parent company, or external fund management; it operates as an independent membership collective led by founder and manager William Swiggart alongside long-standing members Norm Meisner and Richard Noyes.

Name

Beacon Angels

Legal name

Beacon Angels

Website

https://beaconangels.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Boston-based angel investment group founded in 2006 that deploys $50,000 to $400,000 equity tickets into early-stage New England startups across biotech, medtech, and software, with a member-based investment process and exits ranging from 0.5X to 8X multiples.

Ownership category

akta.pro rank

Product category

Angel Investing / Private Equity Investment Services

NAICS

Other Investment Pools and Funds (5259), Portfolio Management and Investment Advice (523940)

SIC

Investors, Nec (6799), Investment Advice (6282)

akta.pro primary industry

Micro-VC & Angel Funds (FSANAAAI)

Keywords

• Angel investing group
• Early-stage funding
• Startup seed capital
• Accredited investor network
• Private investment club

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales, Others

Revenue model

1. Investment Returns: Beacon Angels generates returns through equity investments in early-stage companies. Exits so far have produced multiples from 0.5X to 8X, returning several millions of dollars to member investors with IRR significantly exceeding amounts invested.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Beacon Angels is a Boston-based angel investment group founded in 2006 that invests $50,000 to $400,000 per deal into early-stage, fast-growing New England startup companies. Accredited investor members evaluate funding proposals through structured monthly meetings and screening calls, conduct due diligence, and provide capital along with strategic guidance and network access to portfolio companies. The group returns realized proceeds (historical exits ranging from 0.5X to 8X multiples) to its member investors.

Product overview

Beacon Angels is a Boston-based angel investment group (founded in 2006) that operates as a single unified investment service rather than a platform architecture. The organization provides early-stage funding in the $50,000 to $400,000 range to high-growth New England startups, with proceeds from successful exits (0.5X to 8X multiples) returned to member investors. The group conducts monthly meetings (second Tuesday of each month) and screening meetings (third Tuesday), evaluating funding proposals and hearing updates from portfolio companies. Membership is restricted to accredited investors who gain access to a steady flow of early-stage private investment opportunities.

Differentiator

Problem solved

Functional benefit

Products and services

• Beacon Angels Angel Investment Program Core early-stage angel investment service for fast-growing New England startup companies, providing $50,000 to $400,000 per deal, monthly proposal review meetings, member-led screening and due diligence, strategic guidance, and access to the Beacon Angels member network. Returns realized through equity exits (historical multiples from 0.5X to 8X) are distributed back to member investors.
• Beacon Angels Membership (Accredited Investor) Membership offering restricted to accredited investors, providing a steady flow of early-stage private investment opportunities, shared due diligence workload, and access to the group's network and strategic relationships. Prospective members apply via the website and follow up via [email protected] with the subject line "Beacon Membership."

Quantifiable outcome

• Exits with multiples from 0.5X to 8X
• +1 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core and minor.

• Angel Capital AssociationcoreOthersFormal membership organization for angel investors. Beacon Angels is a member, providing access to industry best practices, networking, and deal flow.
• The Capital NetworkminorStrategic or Co-development PartnerPresented to Beacon Angels members regarding startup support resources and investment readiness programs.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Emerging players

• Golden Seeds: U.S.-wide angel network with strong New England presence focused on women-led companies. Comparable as a member-driven angel group with similar check sizes and a structured deal-screening process, though differentiated by its thesis-driven sector focus.

Others

• Angel Capital Association: Industry trade association for U.S. angel investors, of which Beacon Angels is a formal member. Not a direct competitor but a comparable ecosystem participant providing deal-flow infrastructure, education, and syndication opportunities to its member groups.

Direct peers

• Launchpad Venture Group: Boston-area angel group that led the $1.785M Surgicure Technologies seed round with Beacon Angels as co-investor (Mar 2025). Comparable due to similar check sizes, monthly-meeting cadence, and shared New England focus.
• TiE Boston Angels: Boston chapter of TiE's global angel network investing in early-stage ventures, with overlapping co-investment activity on GelMEDIX. Comparable because both groups run member-driven diligence processes targeting New England startups.
• Mass Medical Angels: Boston-area angel group focused on medical and healthcare ventures; co-invested with Beacon on Avaxia Biologics. Highly comparable in geography and member-based structure, with a healthcare/life-sciences tilt that overlaps Beacon's biotech portfolio bias.
• Boston Harbor Angels: Boston-based angel investment group investing in early-stage New England companies. Direct comparable because it operates the same member-based, monthly-meeting model in the same geography and has co-invested alongside Beacon Angels on GelMEDIX ($13M seed, Feb 2026).
• North Country Angels: New Hampshire-based angel group with New England focus that co-invested alongside Beacon on Avaxia Biologics. Comparable as a regional angel group with similar monthly-meeting cadence and deal-size range.
• Common Angels: Boston-area angel network investing in early-stage New England companies. Comparable in operating model, geographic focus, and check-size range; one of the longest-running independent angel groups in Boston.
• Cherrystone Angels: Rhode Island/New England angel group that co-invested with Beacon on Avaxia Biologics' $4.1M Series A (2012). Comparable member-driven angel model with similar check sizes and stage focus in the same region.

Broad incumbents

• Techstars Mentorship-Driven Accelerator: Large global accelerator/early-stage investor with active Boston programs. Comparable as a source of seed-stage deal flow in New England and as a co-investment partner, though structurally different in deploying institutional capital rather than pooling member checks.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/sharer/sharer.php?u=https%3A%2F%2Fbeaconangels.com%2F
• Xx.com/beaconangels
• LinkedInlinkedin.com/company/beacon-angels

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments33 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beacon Angels